The effect of the oral contraceptive Ovosiston on the composition of human milk.
D000328:Adult; D000418:Albumins / Q000032:analysis; D002364:Caseins / Q000032:analysis; D002712:Chlorides / Q000032:analysis; D002715:Chlormadinone Acetate / Q000008:administration & dosage / Q000494:pharmacology*; D003276:Contraceptives, Oral / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007782:Lactoglobulins / Q000032:analysis; D007785:Lactose / Q000032:analysis; D008055:Lipids / Q000032:analysis; D008656:Mestranol / Q000008:administration & dosage / Q000494:pharmacology*; D008895:Milk, Human / Q000032:analysis*; D011247:Pregnancy
D000418:Albumins; D002364:Caseins; D002712:Chlorides; D003276:Contraceptives, Oral; D007136:Immunoglobulins; D007782:Lactoglobulins; D008055:Lipids; D002715:Chlormadinone Acetate; D008656:Mestranol; D007785:Lactose